Cardio Diagnostics Holdings, Inc.
CDIO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
Other share classesCDIOW
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
17
- +1 vs. Q1 2026
- Total value $422.73K
Superinvestors holding CDIO
0
- None of the superinvestors held CDIO at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by CDIO insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 20241:18 PM ETAmended | Sep 6, 2024 | Dogan TimurChief Technology Officer | PPurchaseCommon Stock | +68.97K | $0.29 | +$20K | 197.31K | +53.7% | SEC |
| Oct 8, 202410:42 AM ETAmended | Sep 6, 2024 | Dogan MeeshanthiniChief Executive Officer | PPurchaseCommon Stock | +68.97K | $0.29 | +$20K | 1.66M | +4.3% | SEC |
| Sep 10, 20245:22 PM ET | Sep 6, 2024 | Philibert RobertChief Medical Officer | PPurchaseCommon Stock | +34.08K | $0.2865 | +$9.76K | 1.68M | +2.1% | SEC |
| Sep 9, 202411:08 AM ET | Sep 6, 2024 | Dogan MeeshanthiniChief Technology Officer | PPurchaseCommon Stock | +68.97K | $0.29 | +$20K | 197.31K | +53.7% | SEC |
| Sep 9, 202411:01 AM ET | Sep 6, 2024 | Dogan MeeshanthiniChief Executive Officer | PPurchaseCommon Stock | +68.97K | $0.29 | +$20K | 1.68M | +4.3% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in CDIO at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 49,200 | $107.75K | 0.00% | +33,852+220.6% | Added |
| BlackRock, Inc. | 34,708 | $76.01K | 0.00% | 00.0% | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | 26,233 | $57.45K | 0.00% | −5,944−18.5% | Reduced |
| VANGUARD CAPITAL MANAGEMENT LLC | 20,155 | $44.14K | 0.00% | 00.0% | Unchanged |
| CITADEL ADVISORS LLC | 19,071 | $41.77K | 0.00% | +19,071 | New |